Taishin Financial Holding

Taishin Financial Holding Co., Ltd. is a major financial services conglomerate headquartered in Taipei, Taiwan, providing comprehensive banking, securities, insurance, and asset management services. The company operates through several key subsidiaries, including Taishin International Bank and Taishin Securities, and maintains a leading position in digital banking and wealth management. In the life sciences and healthcare industries, Taishin serves as a strategic institutional investor and capital partner through its specialized investment vehicles, such as Taishin Health Investment and Taishin Venture Capital. A notable sector activity includes a landmark partnership with Bora Pharmaceuticals to invest in global contract development and manufacturing organizations (CDMOs), specifically targeting cell and gene therapy expansion. Following a 2025 merger with Shin Kong Financial Holding, the entity became TS Financial Holding, ranking as one of the largest financial conglomerates in Taiwan.